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Introduction
Historically, malaria has been endemic throughout Papua 
New Guinea, except in highland areas over 1600 m, where 
temperatures are low and there is no stable local transmis-
sion, though imported cases and epidemics do occur.1–3 The 
causative parasites Plasmodium falciparum, Plasmodium vivax, 
Plasmodium malariae and Plasmodium ovale are transmitted 
by various Anopheles mosquito species adapted to distinct 
ecological niches.4 The epidemiology of malaria in the country 
and, consequently, its control are complex due to the number 
of parasite and mosquito species present, the variety of mos-
quito behaviour, the diversity of the natural environment and 
operational difficulties.
Since 2004, the country’s national malaria control pro-
gramme has been supported by the Global Fund to Fight AIDS, 
Tuberculosis and Malaria. National campaigns were organized 
to distribute free, long-lasting insecticide-treated nets at the 
household level and, since late 2011, malaria rapid diagnostics 
tests, improved diagnostic microscopy and artemisinin-based 
combination therapy have increasingly been provided at public 
and church-run health-care facilities.5,6
In 2008–2009, towards the end of the first insecticide-
treated net campaign, the Papua New Guinean Institute of 
Medical Research conducted a country-wide malaria indicator 
survey. It documented that 65% of households in areas covered 
by the campaign owned long-lasting insecticide-treated nets 
and that 33% of people were using them.5 In addition, malaria 
was found to be widespread, with a heterogeneous prevalence.7 
Light microscopy diagnosis indicated that P. falciparum was 
the most common species, followed by P. vivax, which domi-
nated in several locations. A few P. malariae infections were 
found but P. ovale was not detected in any sample. Within 
1 year of the initial insecticide-treated net campaign, a signifi-
cant reduction in the prevalence, incidence and transmission 
of malaria was documented at selected sites, even though 
insect vectors tended to feed outdoors.8 However, entomologi-
cal investigations indicated that biting patterns and changes 
in these patterns may reduce the impact of vector control.9
Subsequent national malaria surveys conducted by the 
Papua New Guinean Institute of Medical Research in 2010–
2011 and 2013–2014 to evaluate the national malaria control 
programme provided evidence that coverage with long-lasting 
insecticide-treated nets had increased.6,10 Here, we present 
data on malaria prevalence from these follow-up surveys and 
analyse changes relative to the baseline survey of 2008–2009.
Methods
National malaria surveys were conducted from November 
2010 to August 2011 and from November 2013 to August 
2014. In both surveys, five villages were randomly selected 
from each of the country’s 20 provinces – organized in four 
regions – using a list of villages identified in the 2000 national 
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census – the most up-to-date.11 Not all 
provinces or selected villages could be 
included because of problems with ac-
cess and security. The pre-2012 province 
structure was adopted to ensure com-
parability over time: Hela Province was 
considered part of Southern Highlands 
Province and Jiwaka Province, part of 
Western Highlands Province. For each 
village, the survey team leader selected 
a random sample of 30 households us-
ing a list compiled by village leaders. All 
members of sampled households were 
eligible for inclusion. The sample size, 
which took into account financial and 
operational constraints, was adequate 
for detecting a 25% reduction in para-
sitaemia from 2008–2009 to 2010–2011 
at the regional level at a 95% level of 
significance with 80% power. The first 
survey in 2008–2009, whose results are 
presented for comparison, included 
villages from only districts covered by 
the long-lasting insecticide-treated net 
campaign, but the method of selecting 
households and their members was 
identical to that in subsequent surveys.7
Data were collected using an adapt-
ed Malaria Indicator Survey question-
naire.12 Household heads provided 
details of each household member’s 
demographic characteristics and cover-
age by malaria interventions. A capillary 
blood sample was collected by finger-
stick from each available, consenting 
household member aged over 5 months. 
Trained study nurses prepared one thick 
and one thin blood film for light micros-
copy. The haemoglobin concentration 
was measured using a portable He-
moCue Hb 201+ photometric analyser 
(HemoCue AB, Ängelholm, Sweden). 
Symptomatic household members were 
offered a malaria rapid diagnostic test 
and treatment or referral to the nearest 
health-care facility, where appropriate. 
Axillary temperature was measured 
using an electronic thermometer and 
children aged between 2 and 9 years 
had their spleen palpated. Each patient’s 
blood sample was accompanied by in-
formation on recent travel. The locations 
of the survey villages were determined 
using a hand-held Garmin eTrex Global 
Positioning System device (Garmin Ltd., 
Olathe, United States of America).
Malaria was diagnosed by light 
microscopy at the Papua New Guinean 
Institute of Medical Research following 
established procedures.7,13 Each slide 
was examined independently by two 
microscopists, each viewing a minimum 
of 200 thick film fields. Slides with 
discordant results were examined by a 
third microscopist, who was certified 
at World Health Organization (WHO) 
level 1 or 2. A slide was considered 
positive for malaria if judged positive 
by at least two microscopists. For the 
2010–2011 survey, additional assess-
ments of unclear species identifications 
were performed at the Australian Army 
Malaria Institute in Australia by WHO-
certified level-1 malaria microscopists. 
The number of parasites per 200 white 
blood cells was determined. The study 
was approved by the Papua New Guinea 
Medical Research Advisory Committee 
(MRAC no. 07.30 and no. 10.12).
Table 1. National malaria surveys, Papua New Guinea, 2010–2014





No. (%) No. (%) No. (%) No. (%)
Total 77 (100) 10 060 (100) 92 (100) 8408 (100)
Southern Region
01. Western 3 (3.9) 376 (3.7) 5 (5.4) 504 (6.0)
02. Gulf 4 (5.2) 577 (5.7) 4 (4.3) 504 (6.0)
03. Central 5 (6.5) 814 (8.1) 5 (5.4) 474 (5.6)
04. National Capital District 5 (6.5) 673 (6.7) 4 (4.3) 301 (3.6)
05. Milne Bay 5 (6.5) 721 (7.2) 4 (4.3) 324 (3.9)
06. Oro 5 (6.5) 740 (7.4) 5 (5.4) 631 (7.5)
Total 27 (35.1) 3 901 (38.8) 27 (29.3) 2738 (32.6)
Highlands Region
07. Southern Highlands
    Altitude ≥ 1600 m 4 (5.2) 494 (4.9) 4 (4.3) 335 (4.0)
08. Enga
    Altitude ≥ 1600 m 5 (6.5) 498 (5.0) 6 (6.5) 335 (4.0)
09. Western Highlands
    Altitude < 1600 m 3 (3.9) 295 (2.9) 2 (2.2) 164 (2.0)
    Altitude ≥ 1600 m 2 (2.6) 188 (1.9) 3 (3.3) 213 (2.5)
10. Chimbu
    Altitude < 1600 m 1 (1.3) 140 (1.4) 1 (1.1) 85 (1.0)
    Altitude ≥ 1600 m 3 (3.9) 359 (3.6) 4 (4.3) 253 (3.0)
11. Eastern Highlands
    Altitude < 1600 m ND ND 2 (2.2) 171 (2.0)
    Altitude ≥ 1600 m ND ND 3 (3.3) 258 (3.1)
Total 18 (23.4) 1 974 (19.6) 25 (27.2) 1814 (21.6)
Momase Region
12. Morobe
    Altitude < 1600 m 5 (6.5) 672 (6.7) 3 (3.3) 282 (3.4)
    Altitude ≥ 1600 m 0 (0) 0 (0) 2 (2.2) 142 (1.7)
13. Madang 4 (5.2) 479 (4.8) 5 (5.4) 447 (5.3)
14. East Sepik 5 (6.5) 665 (6.6) 6 (6.5) 461 (5.5)
15. Sandaun 3 (3.9) 403 (4.0) 4 (4.3) 645 (7.7)
Total 17 (22.1) 2 219 (22.1) 20 (21.7) 1977 (23.5)
Islands Region
16. Manus 5 (6.5) 629 (6.3) 5 (5.4) 547 (6.5)
17. New Ireland 5 (6.5) 708 (7.0) 5 (5.4) 494 (5.9)
18. East New Britain 5 (6.5) 629 (6.3) 5 (5.4) 409 (4.9)
19. West New Britain ND ND ND ND
20. Bougainville ND ND 5 (5.4) 429 (5.1)
Total 15 (19.5) 1 966 (19.5) 20 (21.7) 1879 (22.3)
ND: not determined.
a  For security and operational reasons, 23 villages could not be surveyed in 2010 to 2011 and 10 could not 
be surveyed in 2013 to 2014.
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Data analysis
Measures of the prevalence of malaria 
infection and morbidity were age-stan-
dardized using the standard popula-
tion for Asia given by the International 
Network for the Demographic Evalu-
ation of Populations and Their Health 
(INDEPTH).14 Results are presented 
separately for villages below 1600 m in 
altitude and include comparisons with 
data from the 2008–2009 survey. For vil-
lages at 1600 m or higher, we compared 
data from the 2010–2011 and 2013–2014 
surveys only as the 2008–2009 survey 
included few highland villages. To ac-
count for stratified sampling, national 
estimates were weighted, as described 
elsewhere.5 Splenomegaly was defined 
as a palpable spleen (i.e. Hackett grade 
1 to 5) and anaemia was defined accord-
ing to WHO recommendations, which 
include age-specific cut-offs and altitude 
corrections.15 Living in a high-quality 
house served as a proxy for having both 
good sanitation and a relatively high 
socioeconomic status, as defined else-
where.10 Binary variables were compared 
using χ2 tests and logistic regression, and 
non-normally distributed variables were 
compared using the non-parametric 
Mann–Whitney U test. Data analyses 
were conducted using Stata/IC v. 14.0 
(StataCorp LP., College Station, USA) 
and the survey design was taken into 
account by using Statas set of commands 
for survey data analysis (svy).
Results
In the 2010–2011 survey, blood samples 
were collected from 10 060 individuals. 
Of the 77 villages included, 58 (75.3%) 
were below 1200 m in altitude, 5 (6.5%) 
were between 1200 and 1599 m and 14 
(18.2%), with 1539 participants, were 
at 1600 m or higher (Table 1). In the 
2013–2014 survey, blood samples were 
collected from 8408 individuals. Of the 
92 villages included, 66 (71.7%) were 
below 1200 m, 4 (4.3%) were between 
1200 and 1599 m and 22 (23.9%), with 
1536 participants, were at 1600 m or 
higher (Table 1). The small number 
of villages at intermediate altitudes 
reflects the population distribution in 
Papua New Guinea.1 The age distribu-
tion of survey participants is shown in 
Table 2. In the 2010–2011 survey, the 
participants’ median age was 19 years 
(interquartile range, IQR: 8–36): 14.1% 
(1418/10 060) were aged under 5 years 
Table 2. Age of participants, national malaria surveys, Papua New Guinea, 2010–2014
Age, years 2010–2011 survey 2013–2014 survey
 No. (%) No. (%)
< 1 72 (0.7) 95 (1.1)
1–4 1346 (13.4) 890 (10.6)
5–9 1621 (16.1) 1218 (14.5)
10–14 1137 (11.3) 944 (11.2)
15–19 888 (8.8) 728 (8.7)
20–39 2885 (28.7) 2510 (29.9)
≥ 40 2080 (20.7) 1967 (23.4)
Missing values 31 (0.3) 56 (0.7)
Total 10060 (100) 8408 (100)
Table 3. Age-standardized prevalence of Plasmodium infection below 1600m, by 
species, national malaria surveys, Papua New Guinea, 2008–2014
Plasmodium species Infection prevalence 
% (95% CI)
2008–2009 surveya 2010–2011 survey 2013–2014 survey
(n = 6424)b (n = 8521)b (n = 6872)b
All species 11.1 (8.5–14.3) 5.1 (3.6–7.4) 0.9 (0.6–1.5)
P. falciparum 6.6 (4.9–8.8) 3.0 (1.9–4.6) 0.8 (0.5–1.2)
P. vivax 3.1 (1.9–4.9) 2.0 (1.4–2.9) 0.1 (0.0–0.3)
P. malariae 0.3 (0.1–0.6) 0.1 (0.0–0.2) 0
P. falciparum and P. vivax 0.3 (0.1–0.5) 0.2 (0.1–0.4) 0.01 (0.0–0.08)
CI: confidence interval; P. falciparum: Plasmodium falciparum; P. malariae: Plasmodium malariae; P. vivax: 
Plasmodium vivax.
a  Data from the 2008–2009 survey7 were re-analysed by applying age-standardization.
b  The number of survey participants living in villages below 1600 m in altitude.
Fig. 1. Age-standardized prevalence of Plasmodium infection and insecticide-treated 
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P. falciparum: Plasmodium falciparum; P. vivax: Plasmodium vivax.
Note: Error bars represent 95% confidence intervals.
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and 52.8% (5290/10 028) were female. In 
the 2013–2014 survey, the comparable 
figures were 22 years (IQR: 9–38), 11.7% 
(985/8408) and 52.3% (4363/8348), 
respectively.
Malaria prevalence
Nationally, in villages below 1600 m in 
altitude, the age-standardized preva-
lence of malaria, as diagnosed by light 
microscopy, decreased significantly from 
11.1% (95% confidence interval, CI: 
8.5–14.3) in 2008–2009 to 5.1% (95% CI: 
3.6–7.4) in 2010–2011 (P < 0.001) and 
to 0.9% (95% CI: 0.6–1.5) in 2013–2014 
(P < 0.001). The prevalence of P. falci-
parum infection was higher than that of 
P. vivax infection in all surveys (Table 3). 
There was no evidence of P. ovale in 
any sample. For individual Plasmo-
dium species, the difference in infection 
prevalence between subsequent surveys 
was significant at a P-value ≤ 0.001 for 
all comparisons except for P. malariae 
infection, for which the P-value for the 
difference between subsequent surveys 
was < 0.05, and for mixed P. falciparum 
and P. vivax infection between the 2008–
2009 and 2010–2011 surveys, where the 
decrease was not significant.
Between the 2008–2009 and 2010–
2011 surveys, an increase in the preva-
lence of P. vivax infection was noted 
in two of the country’s four regions 
(Fig. 1) and in several provinces (Fig. 
2 and Fig. 3), which led to a decrease 
in the ratio of P. falciparum to P. vivax 
infection. However, the prevalence of 
infection by both species decreased in 
all provinces between 2010–2011 and 
2013–2014. In 2013–2014, no parasites 
were detected in any sample from 11 
of the 19 provinces surveyed (Table 4; 
available at: http://www.who.int/bul-
letin/volumes/94/10/16-189902). 
Fig 2. Age-standardized prevalence of Plasmodium infection and insecticide-treated net use in lower-prevalence areas, by province and 






































































































































P. falciparum: Plasmodium falciparum; P. vivax: Plasmodium vivax.
Bull World Health Organ 2017;95:695–705B| doi: http://dx.doi.org/10.2471/BLT.16.189902 699
Research
Malaria in Papua New GuineaManuel W Hetzel et al.
In highland villages at 1600 m and 
above, the age-standardized prevalence 
of malaria decreased from 0.7% (95% 
CI: 0.3–1.2) in 2010–2011 to 0.1% (95% 
CI: 0–0.7) in 2013–2014 (P = 0.004). In 
the 2010–2011 survey, the prevalence of 
P. falciparum infection was higher than 
that of P. vivax infection in highland 
villages: 0.6% (95% CI: 0.3–1.1) and 
0.1% (95% CI: 0–0.7), respectively. In the 
2013–2014 survey, the prevalence of P. 
falciparum infection was 0.1% (95% CI: 
0–0.4), whereas no P. vivax infections 
were detected. Moreover, no P. malariae, 
P. ovale or mixed infections were found.
Predictors of infection
Regression analysis findings are pre-
sented in Table 5. Univariable logistic 
regression found that, in 2010–2011, 
malaria infection was significantly 
less likely above 1600 m (odds ratio, 
OR: 0.15; 95% CI: 0.06–0.38); in 2013–
2014, the corresponding OR was  0.04 
(95% CI: 0.00–0.33). The prevalence of 
infection below 1600 m was significantly 
Fig 3. Age-standardized prevalence of Plasmodium infection and insecticide-treated net use in higher-prevalence areas, by province 
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P. falciparum: Plasmodium falciparum; P. vivax: Plasmodium vivax.
Table 5. Factors associated with malaria infection, national malaria surveys, Papua New 
Guinea, 2010–2014





    OR (95% CI)    aOR (95% CI)
2010–2011 survey
Village at 1600 m or higher 0.15 (0.06–0.38) 0.16 (0.06–0.42)
Age < 5 years 2.98 (2.40–3.71) 2.59 (2.08–3.23)
Long-lasting insecticide-treated net 
use
1.38 (1.00–1.90) 1.09 (0.82–1.45)
High-quality housea 0.30 (0.11–0.83) 0.25 (0.08–0.79)
Percentage net use in village 1.01 (1.00–1.02)            ND
2013–2014 survey
Village at 1600 m or higher 0.04 (0.00–0.33) 0.04 (0.00–0.36)
Age < 5 years 1.59 (0.74–3.44) 1.47 (0.68–3.21)
Long-lasting insecticide-treated net 
use
1.42 (0.83–2.45) 1.08 (0.64–1.82)
High-quality housea 1.00            ND
Percentage net use in village 1.01 (1.00–1.03)            ND
aOR: adjusted odds ratio; CI: confidence interval; ND: not determined; OR: odds ratio.
a  Living in a high-quality house served as a proxy for having both good sanitation and a relatively high 
socioeconomic status.
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lower in older individuals in all years 
(Fig. 4): P < 0.001 for the 2008–2009 
and 2010–2011 surveys and P = 0.03 for 
the 2013–2014 survey. For P. falciparum 
infection, the peak prevalence shifted 
to a younger age between 2008–2009 
and 2010–2011, but there was no cor-
responding change for P. vivax infection 
(Fig. 5). In 2013–2014, the difference in 
the prevalence of P. falciparum and P. 
vivax infection between age groups was 
not significant. However, 62.7% (95% 
CI: 42.2–79.4) of P. vivax infections and 
9.1% (95% CI: 3.4–22.0) of P. falciparum 
infections occurred in children aged 
under 5 years.
Long-lasting insecticide-treated 
nets were used by 32.5% (95% CI: 
27.0–38.4) of the population nation-
ally in 2008–2009,5 by 48.3% (95% CI: 
41.8–54.9) in 2010–201110 and by 53.9% 
(95% CI: 49.4–58.4) in 2013–2014.16 
In the 2008–2009 survey, a significant 
association was found between net use 
and a lower risk of malaria infection 
(adjusted odds ratio, aOR: 0.64; 95% 
CI: 0.54–0.76).7 However, no corre-
sponding association was found in the 
2010–2011 survey (aOR: 1.09; 95% CI: 
0.82–1.45), in an analysis that adjusted 
for altitude, age and housing quality, 
or in the 2013–2014 survey (aOR: 1.08; 
95% CI: 0.64–1.82), in an analysis that 
adjusted for altitude and age (Table 5). In 
2010–2011, people living in high-quality 
houses were significantly less likely to be 
infected (aOR: 0.25; 95% CI: 0.08–0.79). 
Malaria cases were clustered in house-
holds. Univariable analysis found that, 
in 2010–2011, the odds of infection 
were over 26 times higher for individu-
als living with an infected person than 
for those who were not (OR: 25.65; 
95% CI: 16.18–40.67); in 2013–2014, 
the odds were over 77 times higher 
(OR: 77.16; 95% CI: 41.61–143.09). In 
2010–2011, 47% of malaria-infected 
individuals lived in a household with 
another infected person; in 2013–2014, 
the corresponding proportion was 25%.
Morbidity
In all surveys, individuals infected with 
malaria were significantly more likely 
than those without to report a recent 
fever episode, to show symptoms of 
acute fever (i.e. an axillary temperature 
over 37.5 °C), to be anaemic or, in those 
aged 2 to 9 years, to have splenomegaly 
(P < 0.01 for all). Although the propor-
tion of the population with a recent 
Fig. 4. Prevalence of Plasmodium infection below 1600 m, by age and survey date, 



























2008–2009 survey 2010–2011 survey 2013–2014 survey
1 5 10 15 20 40
Note: The study age groups, as indicated in the figure, were 0–0.9, 1.0–4.9, 5.0–9.9, 10.0–14.9, 15.0–19.9, 
20.0–39.9 and ≥40 years.
Fig. 5. Prevalence of P. falciparum and P. vivax infection below 1600 m, by age and 













































Age (years) Age (years)
2008–2009 survey 2010–2011 survey 2013–2014 survey
1 5 10 15 20 40 1 5 10 15 20 40
P. falciparum: Plasmodium falciparum; P. vivax: Plasmodium vivax.
Note: The study age groups, as indicated in the figures, were 0–0.9, 1.0–4.9, 5.0–9.9, 10.0–14.9, 15.0–19.9, 
20.0–39.9 and ≥40 years.
Fig. 6. Participants with a history of fever in villages below 1600 m, national malaria 

































Participants testing positive for malaria
Participants testing negative for malaria
2008-2009 2010-2011 2013-2014
Notes: The black line shows the proportion for each whole survey population. Differences between 
subsequent years in the proportion of the overall population were significant (P < 0.01).
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history of fever decreased over time 
(Fig. 6), the association between ma-
laria infection and a recent history of 
fever became stronger, particularly after 
2010: the OR adjusted for age was 2.05 
(95% CI: 1.41–2.99) in 2008–2009, 
2.57 (95% CI: 1.74–3.81) in 2010–2011 
and 12.34 (95% CI: 4.56–33.33) in 
2013–2014. In 2013–2014, 37.4% of all 
infected individuals reported a recent 
fever episode (Fig. 6) and 3.7% had 
an acute fever (Fig. 7). The prevalence 
of splenomegaly in participants aged 
2 to 9 years also decreased over time 
(Fig. 8) and again the association with 
infection tended to become stronger: 
the OR adjusted for age was 4.72 (95% 
CI: 2.38–9.34) in 2008–2009, 10.0 (95% 
CI: 5.10–19.60) in 2010–2011 and 21.84 
(95% CI: 5.52–88.46) in 2013–2014. 
The prevalence of anaemia remained 
high over time and increased between 
2010–2011 and 2013–2014 (Fig. 9 and 
Fig. 10). Independent of the effect of 
malaria infection, in 2013–2014, anae-
mia was significantly associated with 
residing in a village below 1200 m in 
altitude (aOR: 8.63; 95% CI: 6.66–11.18), 
age under 5 years (aOR: 4.38; 95% CI: 
2.96–6.46) and female sex (aOR: 1.54; 
95% CI: 1.35–1.75).
Discussion
Within 5 years, the prevalence of malar-
ia in Papua New Guinea decreased from 
11.1% to 0.9% and during 2013–2014 no 
parasites were detected by light micros-
copy in most provinces. This is a greater 
reduction than the 26% observed in Af-
rica between 2000 and 2016.17 Moreover, 
the prevalence in 2014 was lower than 
that in other countries in the Asia–Pa-
cific region, including the neighbouring 
Papua province of Indonesia.18–21 An 
initial shift towards proportionally more 
P. vivax than P. falciparum infections ap-
peared to be transient and was followed 
by a clear reduction in both species, as 
observed elsewhere.22,23 These trends 
are in line with previously documented 
declines in malaria following the in-
troduction of long-lasting insecticide-
treated nets.8,9,24 Provinces in which no 
malaria parasites were found should not 
be considered malaria-free because, as 
parasite density decreases, an increasing 
proportion of infections becomes sub-
microscopic,13,18,25 particularly if trans-
mission decreases faster than the loss of 
Fig. 7. Participants with acute fever in villages below 1600 m, national malaria surveys, 





























Participants testing positive for malaria
Participants testing negative for malaria
2008-2009 2010-2011 2013-2014
Notes: The black line shows the proportion for each whole survey population. Differences between 
subsequent years in the proportion of the overall population were significant (P < 0.01).
Fig. 8. Participants aged 2 to 9 years with splenomegaly in villages below 1600 m, 






























Participants testing positive for malaria
Participants testing negative for malaria
2008-2009 2010-2011 2013-2014
Notes: The black line shows the proportion for each whole survey population. Differences between 
subsequent years in the proportion of the overall population were significant (P < 0.01).
Fig. 9. Participants with anaemia in villages below 1600 m, national malaria surveys, 





























Participants testing positive for malaria
Participants testing negative for malaria
2008-2009 2010-2011 2013-2014
Notes: The black line shows the proportion for each whole survey population. Differences between 
subsequent years in the proportion of the overall population were significant (P < 0.01). Anaemia 
was defined according to WHO recommendations, which included age-specific cut-offs and altitude 
corrections.15
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immunity. In three provinces with zero 
prevalence, rapid diagnostic tests found 
that people with fever who had not left 
the province had a current or recent 
infection. Consequently, maintaining 
a high level of intervention coverage 
is crucial for avoiding resurgence. The 
notion that climatic change might have 
increased malaria in the highlands could 
not be substantiated.26 In locations above 
1600 m, malaria prevalence was lower in 
2010–2011 and 2013–2014 than between 
2000 and 2005.2 The protective effect 
of insecticide-treated nets in both the 
highlands and lowlands, from where 
infections are often imported,27 may 
have outweighed the impact of changing 
weather patterns or increased people 
movement. Unlike in previous years,2,3 
P. falciparum was the dominant species 
in the highlands.
The prevalence of fever and sple-
nomegaly declined with that of parasite 
infection. However, the association be-
tween infection and symptoms became 
stronger over time, perhaps because the 
proportion of microscopically detect-
able infections that were symptomatic 
increased as transmission and immunity 
declined. The decrease in splenomegaly 
was most marked, which may reflect a 
reduction in chronic malaria infection.7 
On the other hand, anaemia remained 
common, indicating that the cause is 
multifactorial.28 Anaemia may not, 
therefore, be useful for monitoring 
rapid changes in malaria prevalence.29 
As severe anaemia, in particular, affects 
children’s health and development, its 
causes and appropriate mitigating mea-
sures should be investigated.28,30
Between 2004 and 2012, the dis-
tribution of insecticide-treated nets to 
households was the only large-scale ma-
laria intervention in Papua New Guin-
ea.10 The baseline survey demonstrated a 
strong negative association between net 
coverage and malaria prevalence.7 In the 
absence of other factors, such as major 
economic developments or a prolonged 
drought,9 it is plausible that the drop in 
prevalence between the 2008–2009 and 
2010–2011 surveys resulted from in-
creased provision of nets and measures 
promoting their use. The lack of an as-
sociation between net use and malaria 
prevalence in the last two surveys may 
have been due to factors such as out-
door biting, which sustained disease 
transmission, and the mass effect of net 
use on all community members.31 With 
our survey design, it was not possible to 
quantify the relative contributions of net 
use and artemisinin-based combination 
therapy to the reduction in prevalence. 
Combination therapy was introduced 
in November 2011 and, by late 2012, 
was available at approximately half of 
health-care facilities.32 Nevertheless, 
although the treatment’s gametocidal 
effect can reduce transmission from pa-
tients, its prophylactic effect is limited. 
Moreover, in 2014, only 45% of patients 
with confirmed or suspected malaria 
who attended health-care facilities were 
treated with artemisinin-based combi-
nation therapy,33 which corresponds to 
a population coverage of 19% at best. 
The community benefits of combination 
therapy can be maximized by prompt 
diagnosis and treatment.34 With de-
creasing malaria prevalence, clinicians 
across Papua New Guinea should be 
encouraged to administer antimalarials 
only to people with a positive test result, 
which has proven to be a safe approach,35 
and to thoroughly investigate the causes 
of nonmalarial fevers. Better guidance 
on differential diagnosis and on fever 
management is warranted.36
We found that individuals cohabit-
ing with another infected person were 
more likely to carry parasites, possibly 
due to similar exposure patterns. There 
were fewer infections in high-quality 
houses occupied by better-off house-
holds, possibly because of economic 
factors or the building’s structure or 
location – most high-quality houses were 
in urban areas. Earlier studies in Papua 
New Guinea found conflicting evidence 
of the impact of housing, namely raised 
structures, on mosquito exposure.37,38 As 
indoor exposure to malaria vectors has 
been reduced by nets, people’s outdoor 
behaviour may be an increasingly im-
portant determinant of exposure as many 
vectors tend to bite outdoors.9,39 The in-
vestigation of residual malaria transmis-
sion is crucial for eliminating the disease 
and should take into account human and 
mosquito behaviour patterns, including 
the distribution of different Anopheles 
populations, their biting preferences and 
their susceptibility to interventions.8,9,37
In our study, we used age-stan-
dardization to account for differences 
in the age-composition of participants 
between surveys and between partici-
pants who gave blood samples and the 
general population. However, as the 
2008–2009 survey included only dis-
tricts where nets were distributed, the 
national prevalence of parasite infec-
tion may have been underestimated. 
Data from sentinel sites showed that 
the prevalence after net distribution was 
4.8% compared with 15.7% before.8 In 
addition, the estimated prevalence in the 
2010–2011 and 2013–2014 surveys may 
have been too low because, due to secu-
rity concerns, they excluded West New 
Britain Province, where the prevalence 
is traditionally high.40
In conclusion, increased use of 
long-lasting insecticide-treated nets 
in Papua New Guinea was associated 
with a rapid and significant decline 
in malaria prevalence – the low-
est prevalence ever recorded was in 
2013–2014. The decline also occurred 
in the epidemic-prone highlands. Light 
microscopy showed that P. falciparum 
remained more common than P. vivax. 
Fig. 10. Participants with severe anaemia in villages below 1600 m, national malaria 































Participants testing positive for malaria
Participants testing negative for malaria
2008-2009 2010-2011 2013-2014
Notes: The black line shows the proportion for each whole survey population. Differences between 
subsequent years in the proportion of the overall population were significant (P < 0.01). Severe anaemia 
was defined according to WHO recommendations, which included age-specific cut-offs and altitude 
corrections.15
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صخلم
2014و 2008 ّيماع ينب ام ةترفلا في ةديدلجا اينيغ اوباب في ايرلالما راشتناو يشرلحا ديبلماب ةلجاعلما تايسومانلا
 ةديدلجا  اينيغ  اوباب  في  ايرلالما  راشتنا  تايرغت  في  قيقحتلا  ضرغلا
 ،دتملما لوعفلما تاذ يشرلحا ديبلماب ةَلجاعُلما تايسومانلا عيزوت دعب
 ةدام  لىع  زكترلما  عّمجلما  جلاعلا  حرطو  ،2004  ماع  نم  اًءدب
.2011 ماع في يننيسيميترلأا
-2010 يماع في ايرلاملل ناتيئاصقتسا ناتسارد تيرجُأ ةقيرطلا
 اهرايتخا  مت  ةيرق 92و  77  اتلمشو  .2014-2013و  2011
 يتلا ةسرأ ينثلاثلا دارفأ عيجم مدق ،ةيرق لك في .لياوتلا لىع اًيئاوشع
 صحفلا ةطساوب اهمييقت متو مدلا نم تانيع اًيئاوشع اهرايتخا مت
 لىإ  ةفاضلإابو  .ايرلالماب  ةباصإ  كانه  ناك  اذإ  ام  ةفرعلم  يرهجلما
 هؤارجإ مت يذلا ايرلالما حسم نم تانايبلا لىع لوصلحا مت ،كلذ
.2009-2008 يماع ينب ام ةترفلا في
 ديزي  لا  يتلا  قطانلما  في  ايرلالما  راشتنا  لدعم  ضفخنا  جئاتنلا
 :% 95  غلبي  ةقث  قاطنب(  %  11.1 نم  ترم 1600  نع  اهعافترا
 % 5.1  لىإ  2009–2008  ّيماع  ينب  ام  ةترفلا  في  )14.3–8.5
–2010  ّيماع  ينب  ام  ةترفلا  في  )7.4–3.6  :% 95  ةقث  قاطنب(
 ينب  ام  ةترفلا  في  )1.5–0.6  :% 95  ةقث  قاطنب(  % 0.9و  ،2011
 ةدايز عم ضرلما راشتنا ضافخنا ينعي ماب ،2014–2013 يماع
 اًعويش رثكأ )ةثيبلخا ايرلالما( ”ةيلجنلما ةروصتلما“ تناك .عافترلاا
 ،نكاملأا لك في سيل نكلو لياجمإ لكشب ”ةطيشنلا ةروصتلما“ نم
 لدعمب  ”ةطيشنلا  ةروصتلماب“  ةباصلإا  راشتنا  لدعم  ضفخنا  ماك
 ايرلالما تاباصإ عيمتج متو .”ةيلجنلما ةروصتلماب“ ةباصلإا نم أطبأ
 ينب ام ةترفلا في اهيلإ لصوتلا مت يتلا جئاتنلا لباقم فيو .سرلأا في
 مادختسا ينب يربك طابترا لىع روثعلا متي لم ،2009-2008 يماع
 ضفخنا ماك .ينتيرخلأا ينتساردلا  في راشتنلاا لدعمو ةيسومانلا
 ىودعب  ماهطابترا  حبصأ  نكلو  لاحطلا  مخضتو  ىملحا  راشتنا
.ىوقأ ايرلالما
 لىع  يشرلحا  ديبلماب  ةَلجاعُلما  ةيسومانلا  عيزوت  طبترا  جاتنتسلاا
 في  ايرلالما  راشتنا  في  قوبسم  يرغ  ضافخنا  ثودحب  عساو  قاطن
 ةضرعلما ةعفترلما قطانلما كلذ في ماب ،ةديدلجا اينيغ اوباب ءاحنأ عيجم
 ضافخنا لثم ،رثكأ ةيحص دئاوف ضافخنلاا اذه قفارو .ةئبولأل
 يرغ ىمحلل لضفأ ةيريسر ةرادإ يرفوت مزليو .للاتعلاا تلادعم
.ةيقبتلما ايرلالما لاقتنا لوح ثاحبلأا ءارجإو ةيرلالما
Declining prevalence was accom-
panied by broader health benefits, 
such as decreased morbidity. How-
ever, nonmalarial fever now requires 
better clinical management. Research 
into the drivers of residual malaria 
transmission and the burden and role 
of submicroscopic parasite infection 
are crucial for better targeting of 
interventions and for eliminating the 
disease. ■
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摘要
新几内亚（旧称巴布亚） 2008-2014 年驱虫蚊帐普及率与疟疾患病率
目的 旨在调查自 2004 年开始分发长效驱虫蚊帐并
于 2011 年开始引入青蒿素联合疗法后，新几内亚（旧
称巴布亚）疟疾患病率的变化。
方法 在 2010 年至 2011 年和 2013 年至 2014 期间分别
进行过两次疟疾调查。这两次调查分别包括了 77 个
和 92 个随机选择的村庄。 在每个村庄，30 个随机
选择的家庭的所有成员均提供了血液样本，并通过
光学显微镜评估疟疾感染情况。 另外，数据还来自
于 2008 年至 2009 年进行的疟疾调查。
结果 自 2008 年至 2009 年期间，海拔 1600 米以下的
疟疾患病率从 2008 年至 2009 年的 11.1％（95％ 置信
区间，CI: 8.5–14.3）降到 2010 年至 2011 年的 5.1%
（95% 置信区间，CI ：3.6–7.4）并在 2013 年至 2014 年
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Résumé
Moustiquaires imprégnées d’insecticides et prévalence du paludisme en Papouasie-Nouvelle-Guinée entre 2008 et 2014
Objectif Étudier les changements observés à l’égard de la prévalence 
du paludisme en Papouasie-Nouvelle-Guinée suite à la distribution, 
depuis 2004, de moustiquaires imprégnées d’insecticides de longue durée 
et à l’introduction, depuis 2011, d’une combinaison thérapeutique à base 
d’artémisinine.
Méthodes Deux enquêtes portant sur le paludisme ont été menées 
en 2010-2011 et 2013-2014. Elles incluaient respectivement 77 et 92 villages, 
sélectionnés d’une manière aléatoire. Dans chacun de ces villages, tous les 
membres de 30 foyers sélectionnés aléatoirement ont donné des échantillons 
sanguins et été soumis à un test de dépistage de l’infection palustre par 
microscopie optique. Des données ont par ailleurs été tirées d’une enquête 
sur le paludisme réalisée en 2008-2009.
Résultats La prévalence du paludisme à moins de 1600 m d’altitude est passée 
de 11,1% (intervalle de confiance, IC, à 95%: 8,5–14,3) en 2008–2009 à 5,1% 
(IC à 95%: 3,6–7,4) en 2010–2011 et 0,9% (IC à 95%: 0,6–1,5) en 2013–2014. 
La prévalence diminuait avec l’altitude. Plasmodium falciparum n’était pas 
systématiquement plus courant que P. vivax, mais l’était dans l’ensemble 
et, dans un premier temps, la prévalence de l’infection à P. vivax a diminué 
plus lentement que la prévalence de l’infection à P. falciparum. Les infections 
palustres ont été regroupées par foyers. Contrairement à ce qu’indiquaient 
les résultats obtenus en 2008-2009, aucune corrélation significative entre 
l’utilisation d’une moustiquaire et la prévalence n’a été constatée dans le 
cadre des deux dernières enquêtes. Les prévalences de la fièvre et de la 
splénomégalie ont également diminué, mais leur corrélation avec l’infection 
palustre est devenue plus forte.
Conclusion La distribution à grande échelle de moustiquaires imprégnées 
d’insecticides a été associée à un déclin sans précédent de la prévalence du 
paludisme dans l’ensemble de la Papouasie-Nouvelle-Guinée, et notamment 
dans les régions montagneuses sujettes aux épidémies. Ce déclin s’est 
accompagné d’autres bienfaits sur la santé, et notamment d’une diminution 
de la morbidité. Il est nécessaire d’améliorer la prise en charge clinique de la 
fièvre non palustre ainsi que les recherches sur la transmission résiduelle du 
paludisme.
Резюме
Обработанные инсектицидами сетки и распространенность малярии, Папуа — Новая Гвинея, 2008–
2014 гг.
Цель Изучить изменения в распространенности малярии в 
Папуа — Новой Гвинее после внедрения сеток, обработанных 
инсектицидами длительного действия, с 2004 года и после 
введения в 2011 году комбинированной терапии на основе 
артемизинина.
Методы В 2010–2011 гг. и 2013–2014 гг. были проведены два 
обследования на инфицирование малярией. Они включали 
соответственно 77 и 92 случайно выбранных поселка. В каждом 
поселке все представители 30 случайно отобранных домохозяйств 
сдали образцы крови, которые прошли исследование с 
использованием световой микроскопии на предмет заражения 
малярией. Кроме того, были получены результаты обследования 
на малярию, проведенного в 2008–2009 гг.
Результаты Распространенность малярии на высоте ниже 1600 м 
над уровнем моря снизилась с 11,1% (95%-й доверительный 
интервал, ДИ: 8,5–14,3) в 2008–2009 гг. до 5,1% (95%-й ДИ: 3,6–7,4) 
в 2010–2011 гг. и до 0,9% (95%-й ДИ: 0,6–1,5) в 2013–2014 гг. 
Распространенность инфекции снижалась по мере роста высоты 
над уровнем моря. Возбудитель Plasmodium falciparum встречался 
чаще, чем P. vivax, но не везде, и изначально распространенность 
инфицирования P. vivax снижалась медленнее, чем инфицирование 
P. falciparum. Случаи заболевания малярией концентрировались 
в домашних хозяйствах. В отличие от результатов, полученных 
в 2008–2009 гг., в двух более поздних исследованиях не было 
выявлено существенной взаимосвязи между использованием 
сеток и распространенностью инфекции. Распространенность 
как лихорадки, так и спленомегалии также снизилась, но их 
взаимосвязь с малярией стала более явной.
Вывод Широкомасштабное распространение использования 
сеток, обработанных инсектицидами длительного действия, было 
связано с беспрецедентным снижением распространенности 
малярии во всей Папуа — Новой Гвинее, включая районы, 
подверженные эпидемии. Снижение распространенности 
инфекции сопровождалось более широкими преимуществами 
для здоровья, такими как снижение заболеваемости. Требуется 
введение более качественных клинических протоколов ведения и 
лечения лихорадки, не связанной с малярией, а также проведение 
исследования оставшихся очагов распространения малярии.
Resumen
Mosquiteros tratados con insecticida y prevalencia de la malaria, Papua Nueva Guinea, 2008–2014
Objetivo Investigar los cambios en la prevalencia de la malaria en Papua 
Nueva Guinea tras la distribución de mosquiteros tratados con insecticida 
de larga duración, a partir de 2004, y la introducción de terapias combinadas 
basadas en la artemisinina en 2011.
Métodos Se llevaron a cabo dos encuestas sobre la malaria en 2010–2011 y 
2013–2014. Incluían 77 y 92 aldeas seleccionadas al azar, respectivamente. En 
cada aldea, todos los miembros de 30 hogares seleccionados al azar dieron 
muestras de sangre y se evaluaron de infección de malaria con microscopio 
óptico. Además, se obtuvieron datos de la encuesta sobre la malaria realizada 
en 2008–2009.
Resultados La prevalencia de la malaria por debajo de 1600 m de altitud 
descendió del 11.1% (intervalo de confidencia (IC) del 95%: 8.5–14.3) 
en 2008–2009 al 5.1% (95% IC 3.6–7.4) en 2010–2011 y 0.9% (95% IC 
0.6–1.5) en 2013–2014. La prevalencia descendía con la altitud. Plasmodium 
falciparum fue más común que P. vivax en general, pero no en todas partes e 
inicialmente la prevalencia de la infección P. vivax descendió más lentamente 
que la infección P. falciparum. Las infecciones de malaria se agruparon en 
los hogares. Al contrario que los hallazgos en 2008–2009, no se encontró 
ninguna asociación significativa entre el uso del mosquitero y la prevalencia 
en las dos últimas encuestas. La prevalencia tanto de la fiebre como de la 
esplenomegalia también descendió, pero su asociación con la infección de 
malaria se hizo más fuerte.
Conclusión La distribución de mosquiteros tratados con insecticida a gran 
escala se asoció con un descenso sin precedentes en la prevalencia de la 
malaria en toda Papua Nueva Guinea, incluidas las áreas altas con propensión 
a causar epidemias. El descenso estuvo acompañado de beneficios saludables 
más amplios, como el descenso de la morbilidad. Se requieren una mejor 
gestión clínica de la fiebre no relacionada con la malaria y la investigación de 
la transmisión residual de la malaria.
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